ResMed's 'first-class problems'

ResMed's third-quarter results missed expectations, but it was, in part, a victim of its own success.

Short-term expectations for ResMed had probably got a bit ahead of reality, with the stock having risen 78% since October, but they came down with a bump after the company missed revenue expectations for its third quarter and reported a slight fall in gross profit. The stock ended the day 10% lower.


SMS Code Sent…

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Log in to access this content

Looks you are already a member. Please enter your password to proceed

Hi {{ user.FirstName }}

Verify your mobile number to unlock a FREE trial

Looks like you've already taken a free trial

Please sign up for full access

Updating information

Please wait ...

Related Articles